Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fareed

Showing results (141-150 of 384) with videos related to

Pageof 39
Sort By:
Seminars in Thrombosis and Hemostasis|July 1, 1989
Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerationsJ M Walenga, R Pifarre, D A Hoppensteadt, et al.
Thrombosis Research|March 1, 1996
Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349)L H Yang, D Callas, J M Herbert, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Inhibition of serine proteases by low molecular weight peptides and their derivativesJ Fareed, H L Messmore, G Kindel, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Modulation of laboratory parameters after therapeutic and prophylactic administration of SandoparinD A Hoppensteadt, S Haas, H K Breddin, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractionsJ M Walenga, L Bara, M M Samama, et al.
Thrombosis Research|May 1, 1994
Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombinD Callas, P Bacher, O Iqbal, et al.
Thrombosis Research|March 8, 2000
Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human bloodT W Stief, J Kurz, M O Doss, et al.
Thrombosis Research|May 1, 1995
Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfateS Alban, W Jeske, D Welzel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor antigen levels in various biological fluidsJ Fareed, D D Callas, D Hoppensteadt, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparinD A Hoppensteadt, W Jeske, J Fareed, et al.
Pageof 39

Showing results (141-150 of 384) with videos related to

Sort By:
Pageof 39
Seminars in Thrombosis and Hemostasis|July 1, 1989
Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerationsJ M Walenga, R Pifarre, D A Hoppensteadt, et al.
Thrombosis Research|March 1, 1996
Modulation of platelet function and vascular smooth muscle contractile actions by a novel, selective, highly potent 5-HT2 antagonist (SR46349)L H Yang, D Callas, J M Herbert, et al.
Annals of the New York Academy of Sciences|January 1, 1981
Inhibition of serine proteases by low molecular weight peptides and their derivativesJ Fareed, H L Messmore, G Kindel, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1993
Modulation of laboratory parameters after therapeutic and prophylactic administration of SandoparinD A Hoppensteadt, S Haas, H K Breddin, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1985
Amidolytic antifactor Xa assays in the laboratory evaluation of heparin and low molecular weight fractionsJ M Walenga, L Bara, M M Samama, et al.
Thrombosis Research|May 1, 1994
Fibrinolytic compromise by simultaneous administration of site-directed inhibitors of thrombinD Callas, P Bacher, O Iqbal, et al.
Thrombosis Research|March 8, 2000
Singlet oxygen inactivates fibrinogen, factor V, factor VIII, factor X, and platelet aggregation of human bloodT W Stief, J Kurz, M O Doss, et al.
Thrombosis Research|May 1, 1995
Anticoagulant and antithrombotic actions of a semisynthetic beta-1,3-glucan sulfateS Alban, W Jeske, D Welzel, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
Tissue factor antigen levels in various biological fluidsJ Fareed, D D Callas, D Hoppensteadt, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 1, 1995
The role of tissue factor pathway inhibitor in the mediation of the antithrombotic actions of heparin and low-molecular-weight heparinD A Hoppensteadt, W Jeske, J Fareed, et al.
Pageof 39